135 related articles for article (PubMed ID: 29977134)
1. Continuous production process of retroviral vector for adoptive T- cell therapy.
Inwood S; Xu H; Black MA; Betenbaugh MJ; Feldman S; Shiloach J
Biochem Eng J; 2018 Apr; 132():145-151. PubMed ID: 29977134
[TBL] [Abstract][Full Text] [Related]
2. Large-scale clinical-grade retroviral vector production in a fixed-bed bioreactor.
Wang X; Olszewska M; Qu J; Wasielewska T; Bartido S; Hermetet G; Sadelain M; Rivière I
J Immunother; 2015 Apr; 38(3):127-35. PubMed ID: 25751502
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different bioreactor systems for the production of high titer retroviral vectors.
Merten OW; Cruz PE; Rochette C; Geny-Fiamma C; Bouquet C; Gonçalves D; Danos O; Carrondo MJ
Biotechnol Prog; 2001; 17(2):326-35. PubMed ID: 11312711
[TBL] [Abstract][Full Text] [Related]
4. Production of retroviral vectors in continuous high cell density culture.
Hein MD; Kazenmaier D; van Heuvel Y; Dogra T; Cattaneo M; Kupke SY; Stitz J; Genzel Y; Reichl U
Appl Microbiol Biotechnol; 2023 Oct; 107(19):5947-5961. PubMed ID: 37542575
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a mink enteritis vaccine production process in stirred-tank reactor and Wave Bioreactor microcarrier culture in 1-10 L scale.
Hundt B; Best C; Schlawin N; Kassner H; Genzel Y; Reichl U
Vaccine; 2007 May; 25(20):3987-95. PubMed ID: 17391818
[TBL] [Abstract][Full Text] [Related]
6. Production of oncolytic adenovirus and human mesenchymal stem cells in a single-use, Vertical-Wheel bioreactor system: Impact of bioreactor design on performance of microcarrier-based cell culture processes.
Sousa MF; Silva MM; Giroux D; Hashimura Y; Wesselschmidt R; Lee B; Roldão A; Carrondo MJ; Alves PM; Serra M
Biotechnol Prog; 2015; 31(6):1600-12. PubMed ID: 26289142
[TBL] [Abstract][Full Text] [Related]
7. Packaging cell line characteristics and optimizing retroviral vector titer: the National Gene Vector Laboratory experience.
Reeves L; Smucker P; Cornetta K
Hum Gene Ther; 2000 Oct; 11(15):2093-103. PubMed ID: 11044911
[TBL] [Abstract][Full Text] [Related]
8. Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor.
Ghani K; Garnier A; Coelho H; Transfiguracion J; Trudel P; Kamen A
Biotechnol Bioeng; 2006 Nov; 95(4):653-60. PubMed ID: 16947907
[TBL] [Abstract][Full Text] [Related]
9. Process intensification for lentiviral vector manufacturing using tangential flow depth filtration.
Tona RM; Shah R; Middaugh K; Steve J; Marques J; Roszell BR; Jung C
Mol Ther Methods Clin Dev; 2023 Jun; 29():93-107. PubMed ID: 36994313
[TBL] [Abstract][Full Text] [Related]
10. Novel suspension retroviral packaging cells generated by transposition using transposase encoding mRNA advance vector yields and enable production in bioreactors.
van Heuvel Y; Schatz S; Hein M; Dogra T; Kazenmaier D; Tschorn N; Genzel Y; Stitz J
Front Bioeng Biotechnol; 2023; 11():1076524. PubMed ID: 37082212
[TBL] [Abstract][Full Text] [Related]
11. Closed hollow-fiber bioreactor: a new approach to retroviral vector production.
Pan D; Whitley CB
J Gene Med; 1999; 1(6):433-40. PubMed ID: 10753069
[TBL] [Abstract][Full Text] [Related]
12. Improved methods of retroviral vector transduction and production for gene therapy.
Kotani H; Newton PB; Zhang S; Chiang YL; Otto E; Weaver L; Blaese RM; Anderson WF; McGarrity GJ
Hum Gene Ther; 1994 Jan; 5(1):19-28. PubMed ID: 8155767
[TBL] [Abstract][Full Text] [Related]
13. Phoenix-ampho outperforms PG13 as retroviral packaging cells to transduce human T cells with tumor-specific receptors: implications for clinical immunogene therapy of cancer.
Lamers CH; Willemsen RA; van Elzakker P; van Krimpen BA; Gratama JW; Debets R
Cancer Gene Ther; 2006 May; 13(5):503-9. PubMed ID: 16282986
[TBL] [Abstract][Full Text] [Related]
14. Large-scale microcarrier culture of HEK293T cells and Vero cells in single-use bioreactors.
Yang J; Guertin P; Jia G; Lv Z; Yang H; Ju D
AMB Express; 2019 May; 9(1):70. PubMed ID: 31127400
[TBL] [Abstract][Full Text] [Related]
15. Growth, metabolic activity, and productivity of immobilized and freely suspended CHO cells in perfusion culture.
Hilal-Alnaqbi A; Hu AY; Zhang Z; Al-Rubeai M
Biotechnol Appl Biochem; 2013; 60(4):436-45. PubMed ID: 23701045
[TBL] [Abstract][Full Text] [Related]
16. Retroviral transduction of human CD34+ cells on fibronectin fragment CH-296 is inhibited by high concentrations of vector containing medium.
Relander T; Brun A; Hawley RG; Karlsson S; Richter J
J Gene Med; 2001; 3(3):207-18. PubMed ID: 11437326
[TBL] [Abstract][Full Text] [Related]
17. Construction of a high efficiency retroviral vector for gene therapy of Hunter's syndrome.
Hong Y; Yu SS; Kim JM; Lee K; Na YS; Whitley CB; Sugimoto Y; Kim S
J Gene Med; 2003 Jan; 5(1):18-29. PubMed ID: 12516048
[TBL] [Abstract][Full Text] [Related]
18. Hollow microcarriers for large-scale expansion of anchorage-dependent cells in a stirred bioreactor.
YekrangSafakar A; Acun A; Choi JW; Song E; Zorlutuna P; Park K
Biotechnol Bioeng; 2018 Jul; 115(7):1717-1728. PubMed ID: 29578573
[TBL] [Abstract][Full Text] [Related]
19. Lentiviral Vector Production from a Stable Packaging Cell Line Using a Packed Bed Bioreactor.
Powers AD; Drury JE; Hoehamer CF; Lockey TD; Meagher MM
Mol Ther Methods Clin Dev; 2020 Dec; 19():1-13. PubMed ID: 32995355
[TBL] [Abstract][Full Text] [Related]
20. Justification of continuous packed-bed reactor for retroviral vector production from amphotropic PsiCRIP murine producer cell.
Kang SH; Kim BG; Lee GM
Cytotechnology; 2000 Oct; 34(1-2):151-8. PubMed ID: 19003389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
